[PHARMA] YoY TTM Result on 30-Jun-2018 [#2]

Announcement Date
17-Aug-2018
Admission Sponsor
-
Sponsor
-
Financial Year
31-Dec-2018
Quarter
30-Jun-2018 [#2]
Profit Trend
QoQ- -7.88%
YoY- 18.67%
Quarter Report
View:
Show?
TTM Result
30/06/21 30/06/20 30/06/19 30/06/18 30/06/17 30/06/16 30/06/15 CAGR
Revenue 3,230,009 2,898,216 2,572,302 2,388,351 2,234,292 2,295,554 2,113,938 7.31%
PBT 44,355 -189,383 72,267 75,814 61,919 97,079 126,467 -16.00%
Tax -13,392 43,048 -23,482 -26,481 -21,162 -26,952 -26,277 -10.61%
NP 30,963 -146,335 48,785 49,333 40,757 70,127 100,190 -17.76%
-
NP to SH 31,951 -145,739 48,386 48,260 40,668 69,407 99,663 -17.25%
-
Tax Rate 30.19% - 32.49% 34.93% 34.18% 27.76% 20.78% -
Total Cost 3,199,046 3,044,551 2,523,517 2,339,018 2,193,535 2,225,427 2,013,748 8.01%
-
Net Worth 357,275 357,891 518,564 519,642 542,147 524,177 528,477 -6.31%
Dividend
30/06/21 30/06/20 30/06/19 30/06/18 30/06/17 30/06/16 30/06/15 CAGR
Div 36,634 22,204 40,348 51,929 38,883 64,750 88,011 -13.57%
Div Payout % 114.66% 0.00% 83.39% 107.60% 95.61% 93.29% 88.31% -
Equity
30/06/21 30/06/20 30/06/19 30/06/18 30/06/17 30/06/16 30/06/15 CAGR
Net Worth 357,275 357,891 518,564 519,642 542,147 524,177 528,477 -6.31%
NOSH 261,991 261,705 261,229 259,821 259,400 258,981 259,057 0.18%
Ratio Analysis
30/06/21 30/06/20 30/06/19 30/06/18 30/06/17 30/06/16 30/06/15 CAGR
NP Margin 0.96% -5.05% 1.90% 2.07% 1.82% 3.05% 4.74% -
ROE 8.94% -40.72% 9.33% 9.29% 7.50% 13.24% 18.86% -
Per Share
30/06/21 30/06/20 30/06/19 30/06/18 30/06/17 30/06/16 30/06/15 CAGR
RPS 246.81 1,109.43 987.13 919.23 861.33 886.38 816.01 -18.05%
EPS 2.44 -55.79 18.57 18.57 15.68 26.80 38.47 -36.82%
DPS 2.80 8.50 15.50 20.00 15.00 25.00 34.00 -34.01%
NAPS 0.273 1.37 1.99 2.00 2.09 2.024 2.04 -28.45%
Adjusted Per Share Value based on latest NOSH - 259,821
30/06/21 30/06/20 30/06/19 30/06/18 30/06/17 30/06/16 30/06/15 CAGR
RPS 224.11 201.09 178.48 165.71 155.02 159.27 146.67 7.31%
EPS 2.22 -10.11 3.36 3.35 2.82 4.82 6.92 -17.24%
DPS 2.54 1.54 2.80 3.60 2.70 4.49 6.11 -13.59%
NAPS 0.2479 0.2483 0.3598 0.3605 0.3762 0.3637 0.3667 -6.31%
Price Multiplier on Financial Quarter End Date
30/06/21 30/06/20 30/06/19 30/06/18 30/06/17 30/06/16 30/06/15 CAGR
Date 30/06/21 30/06/20 28/06/19 29/06/18 30/06/17 30/06/16 30/06/15 -
Price 5.29 2.22 2.84 2.88 4.58 5.50 7.13 -
P/RPS 2.14 0.20 0.29 0.31 0.53 0.62 0.87 16.16%
P/EPS 216.68 -3.98 15.29 15.51 29.21 20.52 18.53 50.60%
EY 0.46 -25.13 6.54 6.45 3.42 4.87 5.40 -33.64%
DY 0.53 3.83 5.46 6.94 3.28 4.55 4.77 -30.64%
P/NAPS 19.38 1.62 1.43 1.44 2.19 2.72 3.50 32.97%
Price Multiplier on Announcement Date
30/06/21 30/06/20 30/06/19 30/06/18 30/06/17 30/06/16 30/06/15 CAGR
Date 20/08/21 19/08/20 23/08/19 17/08/18 16/08/17 19/08/16 17/08/15 -
Price 0.925 4.42 2.66 3.11 4.19 5.62 5.65 -
P/RPS 0.37 0.40 0.27 0.34 0.49 0.63 0.69 -9.85%
P/EPS 37.89 -7.92 14.33 16.74 26.73 20.97 14.69 17.09%
EY 2.64 -12.62 6.98 5.97 3.74 4.77 6.81 -14.59%
DY 3.03 1.92 5.83 6.43 3.58 4.45 6.02 -10.80%
P/NAPS 3.39 3.23 1.34 1.56 2.00 2.78 2.77 3.42%

PBT = Profit before Tax, NP = Net Profit, NP to SH = Net Profit Attributable to Shareholder, Div = Dividend, NP Margin = Net Profit Margin, ROE = Return on Equity, NOSH = Number of Shares, RPS = Revenue per Share, EPS = Earning Per Share, DPS = Dividend Per Share, NAPS = Net Asset Per Share, EOQ = End of Quarter, ANN = Announcement, P/RPS = Price/Revenue per Share, P/EPS = Price/Earning per Share, P/NAPS = Price/Net Asset per Share, EY = Earning Yield, DY = Dividend Yield.

NOSH is estimated based on the NP to SH and EPS. Div is an estimated figure based on the DPS and NOSH. Net Worth is an estimated figure based on the NAPS and NOSH.

Div Payout %, NP Margin, ROE, DY, QoQ & YoY figures in Percentage; RPS, EPS & DPS's figures in Cent; and NAPS's figures in Dollar.

All figures in '000 unless specified.

Discussions
Be the first to like this. Showing 0 of 0 comments

Post a Comment